Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
50
datasets available to search
ShareScore release 0.9.0
Dataset results
50 results for “virus particle”
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
ClinicalTrials.gov study NCT02669121. IPD Sharing: YES. Countries: 1. Publications: 0.
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
ClinicalTrials.gov study NCT00365716. IPD Sharing: Not stated. Countries: 0. Publications: 11.
Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine
ClinicalTrials.gov study NCT01290419. IPD Sharing: Not stated. Countries: 1. Publications: 7.
A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)
ClinicalTrials.gov study NCT00943722. IPD Sharing: YES. Countries: 0. Publications: 7.
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine
ClinicalTrials.gov study NCT03776994. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
3D reconstruction of HIV virus-like particles from cryo-electron tomography data
<p>3D reconstruction of HIV virus-like particles from cryo-electron tomography data in EMPIAR-10164 and associated particle poses.</p>
A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine
ClinicalTrials.gov study NCT05065983. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older
ClinicalTrials.gov study NCT04622592. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population
ClinicalTrials.gov study NCT02661490. IPD Sharing: YES. Countries: 1. Publications: 0.
Transcriptional effects of SARS-CoV-2 and their VLPs (virus-like particles) on human GM-CSF-derived macrophages
GEO Series GSE224845. Homo sapiens. 36 samples. Type: Expression profiling by high throughput sequencing.
Arabidopsis retrotransposon virus-like-particles and their regulation by epigenetically activated small RNA
GEO Series GSE128932. Arabidopsis thaliana. 48 samples. Type: Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing; Other; Genome binding/occupancy profiling by high throughput sequencing.
In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles [cell line panel]
GEO Series GSE267496. Homo sapiens. 11 samples. Type: Expression profiling by high throughput sequencing; Third-party reanalysis.
In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles (PHH cells)
GEO Series GSE267282. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Immunogenicity and protective efficacy of Marburg virus glycoprotein and virus-like particle-forming mRNA-based vaccines.
GEO Series GSE298124. Cavia porcellus. 49 samples. Type: Expression profiling by high throughput sequencing.
Molecular and cellular responses in agroinfiltrated leaves of Nicotiana benthamiana expressing suppressor of silencing P19 and influenza H5 virus-like particles
GEO Series GSE233178. Nicotiana benthamiana. 15 samples. Type: Expression profiling by high throughput sequencing.
A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2
ClinicalTrials.gov study NCT01596725. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults
ClinicalTrials.gov study NCT02768805. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults
ClinicalTrials.gov study NCT01561768. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.
ClinicalTrials.gov study NCT01991561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine
ClinicalTrials.gov study NCT01072799. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.